JP2000505792A5 - - Google Patents

Download PDF

Info

Publication number
JP2000505792A5
JP2000505792A5 JP1997527060A JP52706097A JP2000505792A5 JP 2000505792 A5 JP2000505792 A5 JP 2000505792A5 JP 1997527060 A JP1997527060 A JP 1997527060A JP 52706097 A JP52706097 A JP 52706097A JP 2000505792 A5 JP2000505792 A5 JP 2000505792A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1997527060A
Other languages
English (en)
Other versions
JP2000505792A (ja
JP4117404B2 (ja
Filing date
Publication date
Priority claimed from US08/592,540 external-priority patent/US5733911A/en
Application filed filed Critical
Publication of JP2000505792A publication Critical patent/JP2000505792A/ja
Publication of JP2000505792A5 publication Critical patent/JP2000505792A5/ja
Application granted granted Critical
Publication of JP4117404B2 publication Critical patent/JP4117404B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Description

Figure 2000505792
Figure 2000505792
Figure 2000505792
Figure 2000505792
Figure 2000505792
Figure 2000505792
Figure 2000505792
JP52706097A 1996-01-26 1997-01-24 ピペラジン誘導体を用いる腫瘍細胞死誘導法 Expired - Fee Related JP4117404B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/592,540 US5733911A (en) 1996-01-26 1996-01-26 Method for inducing death of neoplastic cells using piperazne derivatives
US08/592,540 1996-01-26
PCT/US1997/001231 WO1997026881A1 (en) 1996-01-26 1997-01-24 Method for inducing death of neoplastic cells using piperazine oxirane derivatives

Publications (3)

Publication Number Publication Date
JP2000505792A JP2000505792A (ja) 2000-05-16
JP2000505792A5 true JP2000505792A5 (ja) 2004-11-11
JP4117404B2 JP4117404B2 (ja) 2008-07-16

Family

ID=24371096

Family Applications (1)

Application Number Title Priority Date Filing Date
JP52706097A Expired - Fee Related JP4117404B2 (ja) 1996-01-26 1997-01-24 ピペラジン誘導体を用いる腫瘍細胞死誘導法

Country Status (14)

Country Link
US (3) US5733911A (ja)
EP (1) EP0877614B1 (ja)
JP (1) JP4117404B2 (ja)
KR (1) KR100468271B1 (ja)
CN (1) CN1220490C (ja)
AR (1) AR005569A1 (ja)
AT (1) ATE219676T1 (ja)
AU (1) AU731125B2 (ja)
CA (1) CA2242657A1 (ja)
DE (1) DE69713570T2 (ja)
ID (1) ID18975A (ja)
TW (1) TW475897B (ja)
WO (1) WO1997026881A1 (ja)
ZA (1) ZA97676B (ja)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA000438B1 (ru) * 1995-03-31 1999-08-26 Ниппон Кемифар Ко., Лтд. Производные эпоксиянтарной кислоты
US5733911A (en) * 1996-01-26 1998-03-31 Hitachi Chemical Co., Ltd. Method for inducing death of neoplastic cells using piperazne derivatives
AU8997898A (en) * 1997-09-04 1999-03-22 Nippon Chemiphar Co. Ltd. Epoxysuccinamide derivatives
EP1094063A1 (en) * 1999-10-18 2001-04-25 Applied Research Systems ARS Holding N.V. 9-(Piperazinylalkyl)carbazoles as Bax-modulators
US6376514B1 (en) * 2000-10-17 2002-04-23 The Procter & Gamble Co. Substituted six-membered heterocyclic compounds useful for treating multidrug resistance and compositions and methods thereof
US6693099B2 (en) 2000-10-17 2004-02-17 The Procter & Gamble Company Substituted piperazine compounds optionally containing a quinolyl moiety for treating multidrug resistance
AU2002213408A1 (en) * 2000-10-23 2002-05-06 The Arizona Disease Control Research Commission Anticancer agents based on regulation of protein prenylation
WO2003044535A1 (en) * 2001-11-22 2003-05-30 Mehmet Ozturk Method, antigen and antibody for distinguishing viable and apoptotic cells
CN112472699A (zh) * 2013-07-26 2021-03-12 种族肿瘤学公司 改善比生群及衍生物的治疗益处的组合方法
PL407922A1 (pl) * 2014-04-16 2015-10-26 Wrocławskie Centrum Badań Eit + Spółka Z Ograniczoną Odpowiedzialnością Nowe bisfosfoniany i ich zastosowanie

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55115878A (en) * 1979-02-27 1980-09-06 Taisho Pharmaceut Co Ltd Epoxysuccinic acid derivative
JPS55153778A (en) * 1979-05-17 1980-11-29 Taisho Pharmaceut Co Ltd Epoxysuccinylamino acid derivative
US4474800A (en) * 1980-05-13 1984-10-02 Taisho Pharmaceutical Co., Ltd. Epoxysuccinyl amino acid derivatives
JPS57169478A (en) * 1981-04-10 1982-10-19 Nippon Chemiphar Co Ltd Piperazine derivative
JPS6276A (ja) * 1985-03-26 1987-01-06 Toyo Jozo Co Ltd 酵素阻害性新規物質
JPH0832698B2 (ja) * 1987-05-08 1996-03-29 日本ケミファ株式会社 ピペラジン誘導体
US5214056A (en) * 1989-12-27 1993-05-25 Japan Tobacco Inc. 1,3,2-dioxathiolane oxide derivative
WO1993006143A1 (fr) * 1991-09-19 1993-04-01 Cray Valley Sa Resines de petrole thermiquement stables, leur procede de preparation et leur application a la formulation d'adhesifs thermofusibles
JPH0641067A (ja) * 1992-04-20 1994-02-15 Kitasato Inst:The 新規カルパイン阻害物質ｋｐ−１２４１及びその製造法
ES2124281T3 (es) * 1992-12-25 1999-02-01 Mitsubishi Chem Corp Derivados de alfa-aminocetonas.
US5733911A (en) * 1996-01-26 1998-03-31 Hitachi Chemical Co., Ltd. Method for inducing death of neoplastic cells using piperazne derivatives

Similar Documents

Publication Publication Date Title
JP2000502280A5 (ja)
JP2000501771A5 (ja)
JP2000501599A5 (ja)
JP2000501018A5 (ja)
JP2000500076A5 (ja)
JP2000501324A5 (ja)
JP2000500055A5 (ja)
JP2000500026A5 (ja)
JP2000502472A5 (ja)
JP2000501338A5 (ja)
JP2000501825A5 (ja)
JP2000500874A5 (ja)
JP2000502485A5 (ja)
JP2000501774A5 (ja)
JP2000502425A5 (ja)
JP2000502570A5 (ja)
JP2000502568A5 (ja)
JP2000500912A5 (ja)
JP2000501876A5 (ja)
JP2000501744A5 (ja)
JP2000502316A5 (ja)
JP2000500857A5 (ja)
JP2000501229A5 (ja)
JP2000500318A5 (ja)
JP2000501569A5 (ja)